Stuart Walter Peltz - Jan 7, 2022 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
Chief Executive Officer, Director
Signature
/s/ Avraham S. Adler, attorney-in-fact
Stock symbol
PTCT
Transactions as of
Jan 7, 2022
Transactions value $
-$83,330
Form type
4
Date filed
1/11/2022, 03:16 PM
Previous filing
Jan 6, 2022
Next filing
Jan 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Sale -$72K -1.87K -2.33% $38.53 78.4K Jan 7, 2022 Direct F1
transaction PTCT Common Stock Award $0 +44K +56.09% $0.00 122K Jan 7, 2022 Direct F2
transaction PTCT Common Stock Sale -$11.3K -294 -1.29% $38.53 22.5K Jan 7, 2022 By Spouse F3
transaction PTCT Common Stock Award $0 +16.8K +74.53% $0.00 39.3K Jan 7, 2022 By Spouse F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTCT Stock Option (Right to Buy) Award $0 +165K $0.00 165K Jan 7, 2022 Common Stock 165K $38.10 Direct F4
transaction PTCT Stock Option (Right to Buy) Award $0 +63K $0.00 63K Jan 7, 2022 Common Stock 63K $38.10 By Spouse F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 6,900 RSUs from a January 6, 2021 grant of 27,600 RSUs.
F2 Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023.
F3 Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 990 RSUs from a January 6, 2021 grant of 3,960 RSUs.
F4 This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023.